Professor Dr. med. Wolfram Karges

Professor Dr. med. Wolfram Karges (Univ.-Prof. Dr. med. Wolfram Karges) — Head of the Division of Endocrinology and Diabetology at Medical Clinic III for Gastroenterology, Metabolic Diseases and Intensive Care Medicine, part of the University Hospital Aachen at RWTH Aachen University.

After completing his studies at the universities of Münster and Marburg and working as a junior resident and research fellow at the University Hospital Tübingen and the University Hospital Ulm, Dr. W. Karges defended his thesis for the degree of Doctor of Medicine at the University of Marburg in 1991. Having been awarded a scholarship from the German Research Foundation, Dr. Karges worked from 1993 to 1995 in the immunology department of the children's hospital of the University of Toronto, Canada. In 1995-1996 he received a grant from the J. F. Kennedy Foundation for research at the University of Toronto. From 1996 to 2006 Dr. W. Karges was a research fellow and senior consultant in the Department of Gastroenterology, Endocrinology and Diabetology at the University Hospital Ulm. In 2001 Dr. Karges was awarded a lectureship in internal medicine at the University of Ulm.

Professor Dr. med. W. Karges is a member of the German Nutrition Society (DGE), the German Diabetes Society (DDG), the scientific and medical advisory board of the association of specialists in neuroendocrine tumours (NeT) e.V. and the Society for Endocrinology and Diabetology of North Rhine-Westphalia (DGE); an expert for the pharmaceutical group Pfizer Pharma GmbH; co-author of the textbooks «Internal Medicine in 5 Days» and «Endocrinology and Diabetes», published by Springer; and an internationally recognised clinician-scientist in the treatment of type 1 and type 2 diabetes (including in children), thyroid cancer, pituitary adenoma, acromegaly and diseases of the pancreas.

In 2018 Dr. W. Karges received the honorary title of «Unique Professor of the Year», awarded by RWTH Aachen University.

The doctor's areas of specialisation:

diseases of the thyroid and parathyroid glands;
pituitary disorders;
adrenal gland disorders;
diseases of the pancreas (diabetes mellitus);
lipid metabolism disorders;
bone metabolism disorders (osteoporosis, primary hyperparathyroidism).

Range of diagnostic services

thyroid diagnostics;
thyroid ultrasound;
hormone level testing;
diabetes diagnostics;
differential diagnosis of conditions involving secondary hormonal dysfunction (for example, following the long-term use of hormonal medication);
differential diagnosis of osteoporosis, Paget's disease and osteomalacia, as well as of hyper- and hypocalcaemia;
diagnosis of metabolic disorders accompanied by excess weight, impaired lipid (fat) balance and structural changes in the liver (fatty degeneration, or fatty liver disease);
differential diagnosis of conditions accompanied by persistently elevated blood pressure (phaeochromocytoma, endocrine disorders of water and salt balance);
diagnosis of metabolic disorders accompanied by excess weight, impaired lipid (fat) balance and structural changes in the liver (fatty degeneration, or fatty liver disease).

Range of therapeutic services

tumours of the endocrine glands;
diseases and functional disorders of the adrenal glands involving excess hormone production (Cushing's disease) or hormone deficiency (Addison's disease), Conn's syndrome, phaeochromocytoma);
treatment of hypertension caused by hormonal disorders;
all types of diabetes mellitus (including diabetes during pregnancy, as well as conditions characterised by a secondary rise in blood sugar levels);
pituitary diseases (acromegaly, growth retardation, diabetes insipidus, visual impairment caused by a space-occupying lesion in the region of the sella turcica, secondary dysfunction of the thyroid gland and the gonads);
thyroid diseases (hyperthyroidism, hypothyroidism), treatment of thyroid cancer;
parathyroid dysfunction accompanied by impaired bone metabolism (disorders of calcium, phosphorus and vitamin D metabolism, primary hyperparathyroidism, secondary hyperparathyroidism, parathyroid cancer);
diseases of the endocrine pancreas (neuroendocrine tumours of the pancreas: insulinoma, gastrinoma);
treatment of neuroendocrine tumours of the gastrointestinal tract;
treatment of tumours of the thymus gland;
treatment of multiple endocrine neoplasia (MEN): MEN type I and MEN type II;
metabolic syndrome and obesity;
treatment of diabetes mellitus (patient education and monitoring in type 1 and type 2 diabetes);
gestational diabetes mellitus (dietary changes, therapeutic exercise, insulin therapy);
hypercholesterolaemia (nutritional counselling, cholesterol-lowering drugs);
osteoporosis (individually tailored drug therapy);
individually tailored drug therapy for an over- or underactive thyroid gland.